The metabolic role and therapeutic potential of the microbiome
In a recent review Louise Olofsson and Fredrik discuss how the gut bacterial composition is altered in, and may contribute to, cardiometabolic disease, as well as how the gut bacteria can be targeted to treat and prevent metabolic diseases.
Review article, Endocrine Reviews, 30 January 2022: